BNP Paribas is a global financial services company headquartered in Paris, France. Established in 1848, it operates through two primary divisions: Retail Banking and Services, and Corporate and Institutional Banking. The company offers a wide array of services, including long-term corporate financing, digital banking, wealth management, asset management, and investment services. It also provides global market services, security services, and corporate trade and treasury services to institutional and corporate clients. BNP Paribas Asset Management, a subsidiary, manages funds for individual and institutional investors, focusing on public equity and fixed income markets worldwide. Additionally, BNP Paribas Fortis, a Belgian subsidiary, offers corporate and investment banking, retail banking, and investment solutions. The company's extensive global network spans nearly 75 countries, serving a diverse range of clients from individuals to large corporations and public institutions.
10 Collyer Quay #15-01 Ocean Financial Centre Singapore 049315 / 30/F, Three Exchange Square, 8 Connaught Place, Central, Hong Kong
Stephen Blumenreich
Managing Director, Head of Healthcare
Jean-Laurent Bonnafe
CEO
Jean-Laurent Bonnafe
CEO and Director
Philippe Bordenave
COO
Koen Broothaerts
Investment Director
Rodolphe Brumm JD
Head of Infrastructure, Private Equity and Private Assets investment
Renaat Denolf
COO Private Equity
Steven Van Droogenbroeck
Investment Manager
Toon Frans
Investment Associate
Mark Gevens
Investment Director
Michel Konczaty
Deputy COO and Member of the Executive Committee
Raf Moons Ph.D
Investment Director
Emiel De Saeytyd
Investment Associate
Julie De Schrijver
Investment Analyst
Seppe Seghers
Investment Analyst
Christopher Sked
Managing Director
Jade Taieb
Investment Manager, Private Equity
David Vaillant
Global Head of Finance, Deputy Managing Director BNPP Asset Management Europe
Sven Vermeulen
Investment Manager
Sofie Vermeulen
Investment Manager
Olivier Warnan
Partner, Solar Impulse Venture Fund
Anne Wautier
Investment Manager
Jeff Zoller
Director - US Fund Services
Jacques d'Estais
Deputy COO and Head of International Financial Services
Ghanem Al Araj
Managing Director
Sven Vermeulen
Investment Manager
Past deals in Organic Food
Aphea.Bio
Series C in 2023
Aphea.Bio focuses on developing innovative agricultural products aimed at enhancing crop health and yields. The company specializes in creating next-generation biopesticides derived from natural microorganisms, which serve as sustainable alternatives to traditional chemical pesticides facing regulatory challenges. Additionally, Aphea.Bio produces biostimulants that promote crop growth by enhancing nutrient uptake from the soil. Utilizing proprietary technologies, the company is dedicated to discovering new biocontrol and biostimulant products that help farmers sustainably manage fungal diseases, pests, and weeds, ultimately improving crop productivity and environmental health.
Protix
Private Equity Round in 2022
Protix is an industrial-scale producer of high-quality insect proteins and lipids, aimed at providing sustainable alternatives for animal feed. The company focuses on cultivating insect proteins using a variety of food scraps, including those from meat, fish, and dairy products. By doing so, Protix supports the transition to a more balanced food system that aligns with ecological principles. Its products not only offer low-impact protein solutions but also deliver essential lipids and micro-nutrients, contributing to a more sustainable and organic food supply chain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.